A summary of presentations from the weekly Summit partner webinars
August 27, 2026
FluMist Home: Innovative Approach to Expanding Access to Influenza Vaccination (AstraZeneca) – Allyn Bandell, PharmD, US Medical Lead–Influenza, AstraZeneca
Allyn Bandell, PharmD, described the data from the first year of FluMist Home, an integrated, comprehensive system supporting home vaccination with FLUMIST®️.
mFLUSIVA (Influenza Vaccine, mRNA): Summary of the U.S. Prescribing Information (Moderna) – Wendy Sohn, Executive Director, Moderna
Wendy Sohn summarized the clinical research findings supporting Moderna’s new mRNA influenza vaccine, mFLUSIVA.
Health Care Provider & Caregiver Perspectives on the 2026 Centers for Disease Control and Prevention (CDC) Pediatric Influenza Vaccination Schedule Update: Andrew Rennekamp, PhD, Senior Manager, U.S. Customer Marketing, CSL Seqirus
Andrew Rennekamp, PhD, highlighted the results of a survey about CDC’s shift to recommending shared decision-making about the influenza vaccine instead of a universal recommendation.